trending Market Intelligence /marketintelligence/en/news-insights/trending/5TSXhC90TRvuaMtLpeRkfA2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Omega raises $438M via venture capital fund to invest in life sciences companies

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Street Talk - Ep. 64: Coronavirus jumpstarts digital adoption

Street Talk Podcast

Street Talk - Ep. 63: Deal talks continue amid bank M&A freeze, setting up for strong Q4

Street Talk Podcast

Street Talk - Ep. 62: 'Brutal' outlook for oil demand offers banks in oil patch no relief


Omega raises $438M via venture capital fund to invest in life sciences companies

Boston, Mass.-based investment company Omega Fund Management LLC raised $438 million in capital commitments via its sixth venture capital fund named Omega Fund VI LP.

The company said it will continue its strategy of creating and investing in life sciences companies targeting urgent medical needs.

Omega said investments from Fund VI will use various investment approaches, including company founding and creation, early venture rounds, late-stage public investing and direct secondary transactions.

Omega Fund is an investment company that targets biotechnology and medical device businesses based in North America and Western Europe. According to the company's press release dated Dec. 11, Omega Funds has raised more than $1 billion to invest in entrepreneurs developing products across different therapeutic areas including oncology, immunology, rare diseases and precision medicine since 2004.